Europe Antidiabetic Thiazolidinediones Market Report 2017

Europe Antidiabetic Thiazolidinediones Market Report 2017

1 Antidiabetic Thiazolidinediones Overview

1.1 Product Overview and Scope of Antidiabetic Thiazolidinediones

1.2 Classification of Antidiabetic Thiazolidinediones

1.2.1 Rosiglitazone

1.2.2 Pioglitazone

1.3 Application of Antidiabetic Thiazolidinediones

1.3.1 Hospital

1.3.2 Clinic

1.4 Antidiabetic Thiazolidinediones Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Antidiabetic Thiazolidinediones (2011-2021)

1.5.1 Europe Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2021)

1.5.2 Europe Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

2 Europe Antidiabetic Thiazolidinediones by Manufacturers, Type and Application

2.1 Europe Antidiabetic Thiazolidinediones Market Competition by Manufacturers

2.1.1 Europe Antidiabetic Thiazolidinediones Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Antidiabetic Thiazolidinediones Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Antidiabetic Thiazolidinediones (Volume and Value) by Type

2.2.1 Europe Antidiabetic Thiazolidinediones Sales and Market Share by Type (2011-2016)

2.2.2 Europe Antidiabetic Thiazolidinediones Revenue and Market Share by Type (2011-2016)

2.3 Europe Antidiabetic Thiazolidinediones (Volume and Value) by Countries

2.3.1 Europe Antidiabetic Thiazolidinediones Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Antidiabetic Thiazolidinediones Revenue and Market Share by Countries (2011-2016)

2.4 Europe Antidiabetic Thiazolidinediones (Volume) by Application

3 Germany Antidiabetic Thiazolidinediones (Volume, Value and Sales Price)

3.1 Germany Antidiabetic Thiazolidinediones Sales and Value (2011-2016)

3.1.1 Germany Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

3.1.2 Germany Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

3.1.3 Germany Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

3.2 Germany Antidiabetic Thiazolidinediones Sales and Market Share by Manufacturers

3.3 Germany Antidiabetic Thiazolidinediones Sales and Market Share by Type

3.4 Germany Antidiabetic Thiazolidinediones Sales and Market Share by Application

4 France Antidiabetic Thiazolidinediones (Volume, Value and Sales Price)

4.1 France Antidiabetic Thiazolidinediones Sales and Value (2011-2016)

4.1.1 France Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

4.1.2 France Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

4.1.4 France Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

4.2 France Antidiabetic Thiazolidinediones Sales and Market Share by Manufacturers

4.3 France Antidiabetic Thiazolidinediones Sales and Market Share by Type

4.4 France Antidiabetic Thiazolidinediones Sales and Market Share by Application

5 UK Antidiabetic Thiazolidinediones (Volume, Value and Sales Price)

5.1 UK Antidiabetic Thiazolidinediones Sales and Value (2011-2016)

5.1.1 UK Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

5.1.2 UK Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

5.1.5 UK Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

5.2 UK Antidiabetic Thiazolidinediones Sales and Market Share by Manufacturers

5.3 UK Antidiabetic Thiazolidinediones Sales and Market Share by Type

5.4 UK Antidiabetic Thiazolidinediones Sales and Market Share by Application

6 Russia Antidiabetic Thiazolidinediones (Volume, Value and Sales Price)

6.1 Russia Antidiabetic Thiazolidinediones Sales and Value (2011-2016)

6.1.1 Russia Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

6.1.2 Russia Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

6.1.6 Russia Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

6.2 Russia Antidiabetic Thiazolidinediones Sales and Market Share by Manufacturers

6.3 Russia Antidiabetic Thiazolidinediones Sales and Market Share by Type

6.4 Russia Antidiabetic Thiazolidinediones Sales and Market Share by Application

7 Italy Antidiabetic Thiazolidinediones (Volume, Value and Sales Price)

7.1 Italy Antidiabetic Thiazolidinediones Sales and Value (2011-2016)

7.1.1 Italy Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

7.1.2 Italy Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

7.1.7 Italy Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

7.2 Italy Antidiabetic Thiazolidinediones Sales and Market Share by Manufacturers

7.3 Italy Antidiabetic Thiazolidinediones Sales and Market Share by Type

7.4 Italy Antidiabetic Thiazolidinediones Sales and Market Share by Application

8 Spain Antidiabetic Thiazolidinediones (Volume, Value and Sales Price)

8.1 Spain Antidiabetic Thiazolidinediones Sales and Value (2011-2016)

8.1.1 Spain Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

8.1.2 Spain Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

8.1.8 Spain Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

8.2 Spain Antidiabetic Thiazolidinediones Sales and Market Share by Manufacturers

8.3 Spain Antidiabetic Thiazolidinediones Sales and Market Share by Type

8.4 Spain Antidiabetic Thiazolidinediones Sales and Market Share by Application

9 Benelux Antidiabetic Thiazolidinediones (Volume, Value and Sales Price)

9.1 Benelux Antidiabetic Thiazolidinediones Sales and Value (2011-2016)

9.1.1 Benelux Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

9.1.2 Benelux Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

9.2 Benelux Antidiabetic Thiazolidinediones Sales and Market Share by Manufacturers

9.3 Benelux Antidiabetic Thiazolidinediones Sales and Market Share by Type

9.4 Benelux Antidiabetic Thiazolidinediones Sales and Market Share by Application

10 Europe Antidiabetic Thiazolidinediones Manufacturers Analysis

10.1 Sanofi

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.1.2.1 Rosiglitazone

10.1.2.2 Pioglitazone

10.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Takeda Pharmaceuticals

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.2.2.1 Rosiglitazone

10.2.2.2 Pioglitazone

10.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Eli Lilly

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.3.2.1 Rosiglitazone

10.3.2.2 Pioglitazone

10.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Merck & Co.

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.4.2.1 Rosiglitazone

10.4.2.2 Pioglitazone

10.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Novo Nordisk

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.5.2.1 Rosiglitazone

10.5.2.2 Pioglitazone

10.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Bristol-Myers Squibb

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.6.2.1 Rosiglitazone

10.6.2.2 Pioglitazone

10.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Pfizer

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.7.2.1 Rosiglitazone

10.7.2.2 Pioglitazone

10.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 AstraZeneca

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.8.2.1 Rosiglitazone

10.8.2.2 Pioglitazone

10.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 GlaxoSmithKline

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.9.2.1 Rosiglitazone

10.9.2.2 Pioglitazone

10.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Boehringer Ingelheim

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Antidiabetic Thiazolidinediones Product Type, Application and Specification

10.10.2.1 Rosiglitazone

10.10.2.2 Pioglitazone

10.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

11 Antidiabetic Thiazolidinediones Manufacturing Cost Analysis

11.1 Antidiabetic Thiazolidinediones Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Antidiabetic Thiazolidinediones

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Antidiabetic Thiazolidinediones Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Antidiabetic Thiazolidinediones Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Antidiabetic Thiazolidinediones Market Forecast (2016-2021)

14.1 Germany Antidiabetic Thiazolidinediones Sales Forecast (2016-2021)

14.2 France Antidiabetic Thiazolidinediones Sales Forecast (2016-2021)

14.3 UK Antidiabetic Thiazolidinediones Sales Forecast (2016-2021)

14.4 Russia Antidiabetic Thiazolidinediones Sales Forecast (2016-2021)

14.5 Italy Antidiabetic Thiazolidinediones Sales Forecast (2016-2021)

14.6 Spain Antidiabetic Thiazolidinediones Sales Forecast (2016-2021)

14.7 Benelux Antidiabetic Thiazolidinediones Sales Forecast (2016-2021)

14.8 Europe Antidiabetic Thiazolidinediones Sales Forecast by Type (2016-2021)

14.9 Europe Antidiabetic Thiazolidinediones Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Antidiabetic Thiazolidinediones

Table Classification of Antidiabetic Thiazolidinediones

Figure Europe Sales Market Share of Antidiabetic Thiazolidinediones by Type in 2015

Figure Rosiglitazone Picture

Figure Pioglitazone Picture

Table Application of Antidiabetic Thiazolidinediones

Figure Europe Sales Market Share of Antidiabetic Thiazolidinediones by Application in 2015

Figure Hospital Examples

Figure Clinic Examples

Figure Germany Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Figure France Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Figure UK Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Figure Russia Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Figure Italy Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Figure Spain Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Figure Benelux Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Figure Europe Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2021)

Figure Europe Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2021)

Table Europe Antidiabetic Thiazolidinediones Sales of Key Manufacturers (2015 and 2016)

Table Europe Antidiabetic Thiazolidinediones Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Antidiabetic Thiazolidinediones Sales Share by Manufacturers

Figure 2016 Antidiabetic Thiazolidinediones Sales Share by Manufacturers

Table Europe Antidiabetic Thiazolidinediones Revenue by Manufacturers (2015 and 2016)

Table Europe Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Antidiabetic Thiazolidinediones Revenue Share by Manufacturers

Table 2016 Europe Antidiabetic Thiazolidinediones Revenue Share by Manufacturers

Table Europe Antidiabetic Thiazolidinediones Sales and Market Share by Type (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Sales Share by Type (2011-2016)

Figure Sales Market Share of Antidiabetic Thiazolidinediones by Type (2011-2016)

Figure Europe Antidiabetic Thiazolidinediones Sales Growth Rate by Type (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Revenue and Market Share by Type (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Antidiabetic Thiazolidinediones by Type (2011-2016)

Figure Europe Antidiabetic Thiazolidinediones Revenue Growth Rate by Type (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Sales and Market Share by Countries (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Sales Share by Countries (2011-2016)

Figure Sales Market Share of Antidiabetic Thiazolidinediones by Countries (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Revenue and Market Share by Countries (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Antidiabetic Thiazolidinediones by Countries (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Sales and Market Share by Application (2011-2016)

Table Europe Antidiabetic Thiazolidinediones Sales Share by Application (2011-2016)

Figure Sales Market Share of Antidiabetic Thiazolidinediones by Application (2011-2016)

Figure Germany Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

Figure Germany Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

Figure Germany Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

Table Germany Antidiabetic Thiazolidinediones Sales by Manufacturers (2015 and 2016)

Table Germany Antidiabetic Thiazolidinediones Market Share by Manufacturers (2015 and 2016)

Table Germany Antidiabetic Thiazolidinediones Sales by Type (2015 and 2016)

Table Germany Antidiabetic Thiazolidinediones Market Share by Type (2015 and 2016)

Table Germany Antidiabetic Thiazolidinediones Sales by Application (2015 and 2016)

Table Germany Antidiabetic Thiazolidinediones Market Share by Application (2015 and 2016)

Figure France Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

Figure France Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

Figure France Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

Table France Antidiabetic Thiazolidinediones Sales by Manufacturers (2015 and 2016)

Table France Antidiabetic Thiazolidinediones Market Share by Manufacturers (2015 and 2016)

Table France Antidiabetic Thiazolidinediones Sales by Type (2015 and 2016)

Table France Antidiabetic Thiazolidinediones Market Share by Type (2015 and 2016)

Table France Antidiabetic Thiazolidinediones Sales by Application (2015 and 2016)

Table France Antidiabetic Thiazolidinediones Market Share by Application (2015 and 2016)

Figure UK Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

Figure UK Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

Figure UK Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

Table UK Antidiabetic Thiazolidinediones Sales by Manufacturers (2015 and 2016)

Table UK Antidiabetic Thiazolidinediones Market Share by Manufacturers (2015 and 2016)

Table UK Antidiabetic Thiazolidinediones Sales by Type (2015 and 2016)

Table UK Antidiabetic Thiazolidinediones Market Share by Type (2015 and 2016)

Table UK Antidiabetic Thiazolidinediones Sales by Application (2015 and 2016)

Table UK Antidiabetic Thiazolidinediones Market Share by Application (2015 and 2016)

Figure Russia Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

Figure Russia Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

Figure Russia Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

Table Russia Antidiabetic Thiazolidinediones Sales by Manufacturers (2015 and 2016)

Table Russia Antidiabetic Thiazolidinediones Market Share by Manufacturers (2015 and 2016)

Table Russia Antidiabetic Thiazolidinediones Sales by Type (2015 and 2016)

Table Russia Antidiabetic Thiazolidinediones Market Share by Type (2015 and 2016)

Table Russia Antidiabetic Thiazolidinediones Sales by Application (2015 and 2016)

Table Russia Antidiabetic Thiazolidinediones Market Share by Application (2015 and 2016)

Figure Italy Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

Figure Italy Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

Figure Italy Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

Table Italy Antidiabetic Thiazolidinediones Sales by Manufacturers (2015 and 2016)

Table Italy Antidiabetic Thiazolidinediones Market Share by Manufacturers (2015 and 2016)

Table Italy Antidiabetic Thiazolidinediones Sales by Type (2015 and 2016)

Table Italy Antidiabetic Thiazolidinediones Market Share by Type (2015 and 2016)

Table Italy Antidiabetic Thiazolidinediones Sales by Application (2015 and 2016)

Table Italy Antidiabetic Thiazolidinediones Market Share by Application (2015 and 2016)

Figure Spain Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

Figure Spain Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

Figure Spain Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

Table Spain Antidiabetic Thiazolidinediones Sales by Manufacturers (2015 and 2016)

Table Spain Antidiabetic Thiazolidinediones Market Share by Manufacturers (2015 and 2016)

Table Spain Antidiabetic Thiazolidinediones Sales by Type (2015 and 2016)

Table Spain Antidiabetic Thiazolidinediones Market Share by Type (2015 and 2016)

Table Spain Antidiabetic Thiazolidinediones Sales by Application (2015 and 2016)

Table Spain Antidiabetic Thiazolidinediones Market Share by Application (2015 and 2016)

Figure Benelux Antidiabetic Thiazolidinediones Sales and Growth Rate (2011-2016)

Figure Benelux Antidiabetic Thiazolidinediones Revenue and Growth Rate (2011-2016)

Figure Benelux Antidiabetic Thiazolidinediones Sales Price Trend (2011-2016)

Table Benelux Antidiabetic Thiazolidinediones Sales by Manufacturers (2015 and 2016)

Table Benelux Antidiabetic Thiazolidinediones Market Share by Manufacturers (2015 and 2016)

Table Benelux Antidiabetic Thiazolidinediones Sales by Type (2015 and 2016)

Table Benelux Antidiabetic Thiazolidinediones Market Share by Type (2015 and 2016)

Table Benelux Antidiabetic Thiazolidinediones Sales by Application (2015 and 2016)

Table Benelux Antidiabetic Thiazolidinediones Market Share by Application (2015 and 2016)

Table Antidiabetic Thiazolidinediones Basic Information List

Table Sanofi Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Takeda Pharmaceuticals Basic Information List

Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Merck & Co. Basic Information List

Table Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co. Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antidiabetic Thiazolidinediones

Figure Manufacturing Process Analysis of Antidiabetic Thiazolidinediones

Figure Antidiabetic Thiazolidinediones Industrial Chain Analysis

Table Raw Materials Sources of Antidiabetic Thiazolidinediones Major Manufacturers in 2015

Table Major Buyers of Antidiabetic Thiazolidinediones

Table Distributors/Traders List

Figure Germany Antidiabetic Thiazolidinediones Sales and Growth Rate Forecast (2016-2021)

Figure Germany Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)

Figure France Antidiabetic Thiazolidinediones Sales and Growth Rate Forecast (2016-2021)

Figure France Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)

Figure UK Antidiabetic Thiazolidinediones Sales and Growth Rate Forecast (2016-2021)

Figure UK Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Antidiabetic Thiazolidinediones Sales and Growth Rate Forecast (2016-2021)

Figure Russia Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Antidiabetic Thiazolidinediones Sales and Growth Rate Forecast (2016-2021)

Figure Italy Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Antidiabetic Thiazolidinediones Sales and Growth Rate Forecast (2016-2021)

Figure Spain Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Antidiabetic Thiazolidinediones Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Antidiabetic Thiazolidinediones Revenue and Growth Rate Forecast (2016-2021)

Table Europe Antidiabetic Thiazolidinediones Sales Forecast by Type (2016-2021)

Table Europe Antidiabetic Thiazolidinediones Sales Forecast by Application (2016-2021)